Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTT remdesivir versus placebo in hospitalized adults with COVID-19
jRCT2031190264Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Remdesivir with Placebo (2 arms). Primary endpoint: Clinical status at Day 15. Started Mar 2020; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031190264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031190264.